 |
Andrew Lees UCL-UK Inglaterra |
| Professor of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square and Emeritus Director, Reta Lila Weston Institute of Neurological Studies, University College London, Institute of Neurology Born on Merseyside, Andrew Lees qualified in medicine at the Royal London Hospital Medical College in 1970. His neurological training was at University College London Hospitals and the National Hospital for Neurology and Neurosurgery, Queen Square. He also spent 1 year at L’Hopital Salpetriere, Paris. He has achieved international recognition for his work on Parkinson’s disease and abnormal movement disorders. He is an original member of the Highly-Cited Researchers ISI Database with an h-index of 126. Founder member of the international Movement Disorder Society, he was elected President (2004–2006) and co-edited the Movement Disorders Journal between 1995 and 2003. In 2006, he was awarded the Movement Disorders Research Award by the American Academy of Neurology and he was the recipient of the Association of British Neurologists Medal in 2015. At the age of thirty-two he was appointed to the consultant staff at the National Hospitals, The Middlesex, and Whittington Hospitals and in 1987 was elected a Fellow of the Royal College of Physicians. He was later appointed Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square and was Director of the Reta Lila Weston Institute for Neurological Studies (1998-2012). He was Clinical Director of the Queen Square Brain Bank for Neurological Disorders (1985-2012) and Director of the Sara Koe PSP Research Centre (2002-2012). He is a Visiting Professor at the University of Liverpool and Queen Mary University of London, and has close collaborations with several Brazilian universities. For his contributions to Brazilian neurology he was elected an overseas member of the Academia Nacional de Medicina and the Academia Brasileira de Neurologia. He was elected as a Council member of the Academy of Medical Sciences 2012- 2015. Appointed as an Expert Adviser for the UK Government National Institute for Health and Care Excellence Centre for Guidelines (2006–2019). He received the Bing Spear Award in 2016 for outstanding contributions towards saner drug policies. He has delivered the Gowers Memorial Lecture at the National Hospital, The Inaugural Lord Brain Memorial Lecture at Bart’s and the Royal London Hospitals and David Marsden Memorial Lecture at the European Federation of Neurological Societies. He was the recipient of Stanley Fahn Lectureship Award, MDS Dublin 2012, and has been awarded the German Society of Neurology’s 2012 Dingebauer Prize for outstanding scientific attainment in the field of Parkinson's disease and Neurodegenerative Disorders and the Jay Van Andel award for outstanding research in Parkinson’s disease in 2014 and the Parkinson Canada’s Donald Calne Award and Lectureship for 2017. |
|
 |
Joaquim Ferreira Faculdade de Medicina de Lisboa Portugal |
| Professor de Neurologia e Farmacologia Clínica da Faculdade de Medicina de Lisboa e investigador do Instituto de Medicina Molecular. Atual Presidente da Sociedade Portuguesa das Doenças do Movimento e Presidente eleito e Coordenador do Comité de Educação da Secção Europeia da Sociedade Internacional de Doença de Parkinson. Iniciou as suas atividades na área da doença de Parkinson ainda como aluno da Faculdade de Medicina e mantém, desde então, uma atividade continuada no acompanhamento de doentes parkinsonianos e na investigação desta doença. | |
 |
Marcelo Merello FLENI-AR Argentina |
| Nacido en Argentina en 1961, el Dr. Marcelo Jorge Merello se graduó de Médico en la Facultad de Medicina de Bs As, donde más tarde realizó su doctorado. Realizó su residencia en CEMIC. Su carrera neurológica comenzó en Fleni y en el Methodist de Baylor, USA. Más tarde se desempeño como fellow de neurología del National Hospital Queen Square, Londres (UK) y como Senior Research Registrar en Middlessex Hospital Londres (UK). Es Profesor titular de Enfermedades Neurodegenerativas en la Universidad Catolica de Buenos Aires, Investigador Clinico del CONICET, docente de de la UBA y Director de Neurociencias de Fleni. Fue galardonado por The Michel J Fox foundation con un Word Scientific Award por su trabajo sobre los síntomas no-motores de la Enfermedad de Parkinson. Pionero de la cirugía funcional de movimientos anormales en Latinoamérica. Ha escrito más de 130 trabajos en revistas internacionales y más de 30 capítulos de libros. Más de 300 presentaciones en congresos internacionales y ocho libros entre ellos para prestigiosas editoriales como Cambridge University Press (UK) Demos (US), Elsevier (Holanda) y Random House. Ha integrado varios comités editoriales de prestigiosas revistas donde actualmente actúa como revisor. Es integrante del Comité educativo Internacional y co Director del programa de educación médica continua (CME) de la Sociedad mundial de Parkinson y otros movimientos anormales. Es miembro de varios comités y paneles de expertos internacionales sobre Cirugia de Parkinson, Estimulacion cerebral profunda y usos de neurotoxinas para el tratamiento de enfermedades neurológicas. Es editor en Jefe de la Revista Movement Disorders Clinical Practice editada en US por Jhon Wiley and son. Links de Interés Cómo funciona el cerebro Cuando falla. Cómo se lo cura Una operación de Parkinson Volver a la vida después de la distonía Investigación En 1993 creé en Fleni la Sección de Movimientos Anormales, en el marco del Departamento de Neurociencias y del Instituto de Investigaciones Neurológicas Raúl Carrea. Desde entonces la investigación clínica ha sido una prioridad para todo el equipo de profesionales a mi cargo dentro de esta Sección. El enfoque ha sido desde nuestro nacimiento la investigación interdisciplinaria y traslacional. Viviendo en un ambiente en el que el contacto con la clínica y la patología es permanente, el punto más importante perseguido por nuestro trabajo ha sido que los resultados de las investigaciones realizadas redunden en transferencia hacia la comunidad. Actualmente el equipo de trabajo que dirijo involucra a profesionales y estudiantes de las Ciencias Físicas, Biológicas, la Ingeniería y la Medicina. Sumados al Staff Médico contamos con estudiantes grado, doctorado y post doctorado. El espectro de investigaciones que realizamos en el Grupo de Movimientos Anormales incluye desde el trabajo de laboratorio básico (electrofisiología en un modelo murino de Parkinson, con desarrollo de herramientas matemáticas complejas para el análisis de señales neurológicas) hasta la aplicación de las herramientas desarrolladas en este contexto a los casos clínicos más complejos. Las líneas de investigación que hemos desarrollado pueden agruparse en cuatro categorías principales: 1.- Cirugía funcional para trastornos del movimiento, 2.- Evaluación cinemática en movimientos anormales. 3.- Trastornos no motores de la enfermedad de Parkinson. 4.- Diagnóstico presintomático de la Enfermedad de Parkinson. |
|
 |
Tetsuo Ashizawa Houston Methodist EUA |
| Dr. Tetsuo Ashizawa is Professor of Neurology at Weill Cornell Medical College at Houston Methodist Research Institute. He has chaired two neurology departments, one at UTMB in Galveston, Texas and the other at the University of Florida in Gainesville and served as Executive Director of the McKnight Brain Institute in Gainesville. Dr. Ashizawa has been interested in clinical and basic research on diseases caused by microsatellite repeat expansions. He has established the international myotonic dystrophy consortium (IDMC), which is the world premier basic and clinical research consortium. He was a leader of the NIH-funded Clinical Research Consortium for Spinocerebellar Ataxias (CRC-SCA) studies and continues to contribute to the group. Dr. Ashizawa is serving as corresponding PI of the NIH funded U01 “READISCA” project, which includes investigators from 20 U.S. and 2 European institutions. With increasing knowledge of the disease mechanism, these diseases are entering the clinical trial era, raising hopes for developing efficacious treatments. His basic science research is primarily on the RNA gain-of-function and repeat expansion in SCA10 and myotonic dystrophies. | |
